Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
1636
Srinivasan K and Sharma SS. Sodium phenylbutyrate ameliorates focal cerebral ischemic/reperfusion injury associated with comorbid type 2 diabetes by reducing endoplasmic reticulum stress and DNA fragmentation Behavioural Brain Research 2011, 225, 110-116.
1637
Swarnakar NK, Jain AK, Singh RP, Godugu C, Das M and Jain S. Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles Biomaterials 2011, 32, 6860-6874.
1638
Taxak N, Parmar V, Patel DS, Kotasthane A and Bharatam PV. S-Oxidation of Thiazolidinedione with Hydrogen Peroxide, Peroxynitrous Acid, and C4a-Hydroperoxyflavin: A Theoretical Study Journal of Physical Chemistry. A 2011, 115, 891-898.
1639
Tikoo K, Sane MS and Gupta C. Tannic acid ameliorates doxorubicin-induced cardiotoxicity and potentiates its anti-cancer activity: Potential role of tannins in cancer chemotherapy Toxicology and Applied Pharmacology 2011, 251, 191-200.
1640
Tikoo K, Surse VM and Gupta J. Esculetin induced changes in MMP-13 and BMP-6 gene expression and histone H3 modifications attenuate development of glomerulosclerosis in diabetic rats Journal of Molecular Endocrinology 2011, 46, 245-254.
1641
Toor JS, Sharma A, Kumar R, Gupta P, Garg P and Arora SK. Prediction of drug-resistance in HIV-1 Subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and docking analysis Antiviral Research 2011, 92, 213-218.
1642
Trivedi PP, Kushwaha S, Tripathi DN and Jena GB. Cardioprotective Effects of Hesperetin against Doxorubicin-Induced Oxidative Stress and DNA Damage in Rat Cardiovascular Toxicology 2011, 11, 215-225.
1643
Vekariya KK, Kaur J and Tikoo K. ERα signaling imparts chemotherapeutic selectivity to selenium nanoparticles in breast cancer Nanomedicine: Nanotechnology, Biology and Medicine 2011, 8, 1125-1132.
1644
Vikram A and Jena GB. Role of insulin and testosterone in prostatic growth: Who is doing what? Medical Hypotheses 2011, 76, 474-478.
1645
Vikram A, Jena GB and Ramarao P. Insulin-resistance reduces botulinum neurotoxin-type A induced prostatic atrophy and apoptosis in rats European Journal of Pharmacology 2011, 650, 356-363.
1646
Vikram A, Kushwaha S and Jena GB. Relative influence of testosterone and insulin in the regulation of prostatic cell proliferation and growth Steroids 2011, 76, 416-423.
1647
Wahlang B, Pawar YB, and Bansal AK. Identification of permeability related hurdles in oral delivery of curcumin using the Caco-2 cell model European Journal of Pharmaceutics and Biopharmaceutics 2011, 77, 275-282.
1648
Yadav D, Survase S, and Kumar N. Dual coating of swellable and rupturable polymers on Glipizide loaded MCC pellets for pulsatile delivery: Formulation design and in vitro evaluation International Journal of Pharmaceutics 2011, 419, 121-130.
1649
Adane L and Bharatam PV. Binding modes of 2,4-diaminoquinazoline and 2,4-diaminopteridine analogs to P. falciparum dihydrofolate reductase enzyme: Molecular docking studies Indian Journal of Pharmaceutical Sciences 2010, 72, 324-333.
1650
Adane L, Bharatam PV and Sharma V. A common feature-based 3D-pharmacophore model generation and virtual screening: identification of potential PfDHFR inhibitors Journal of Enzyme Inhibition and Medicinal Chemistry 2010, 25, 635-645.
Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|110|15